A5062232536- Peripheral Neuropathies and Disorders
- Multiple Sclerosis Research Studies
- Transcranial Magnetic Stimulation Studies
- Neuroscience and Neural Engineering
- Pain Management and Treatment
- Autoimmune Bullous Skin Diseases
- EEG and Brain-Computer Interfaces
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Monoclonal and Polyclonal Antibodies Research
- Pain Mechanisms and Treatments
- Cancer Treatment and Pharmacology
- Parkinson's Disease Mechanisms and Treatments
- Long-Term Effects of COVID-19
- Neurological disorders and treatments
- Muscle activation and electromyography studies
- Thermal Regulation in Medicine
- Multiple Myeloma Research and Treatments
- Vagus Nerve Stimulation Research
- Epilepsy research and treatment
- Cardiovascular Syncope and Autonomic Disorders
- Myasthenia Gravis and Thymoma
- Therapeutic Uses of Natural Elements
- Scoliosis diagnosis and treatment
- Advanced MRI Techniques and Applications
- Attention Deficit Hyperactivity Disorder
Université Paris-Est Créteil
2017-2024
Excitabilité Nerveuse et Thérapeutique
2022-2024
Hôpitaux Universitaires Henri-Mondor
2016-2024
Assistance Publique – Hôpitaux de Paris
2019-2024
Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires
2022
Centre Hospitalier Universitaire Henri-Mondor
2016-2018
Patient hospitalized for coronavirus disease 2019 (COVID-19) pulmonary infection can have sequelae such as impaired exercise capacity. We aimed to determine the frequency of long-term capacity limitation in survivors severe COVID-19 and factors associated with this limitation. Patients were enrolled 3 months after hospital discharge COVulnerability, a prospective cohort. They underwent cardiopulmonary testing, function test, echocardiography, skeletal muscle mass evaluation. Among 105...
Peripheral neuropathy is a frequent complication of brentuximab vedotin (BV), used in CD30+ lymphoma treatment. Classic BV-induced (BV-CN) mild distal sensory axonal polyneuropathy. Severe inflammatory neuropathies (BV-IN) have been described. BV-IN contribute to lymphoma-associated morbidity but might be immunotherapy-responsive. Our primary objective was evaluate the rate BV-IN. secondary objectives were determine risk factors and warning signs.
Background: Maximum safe resection of infiltrative brain tumors in eloquent area is the primary objective surgical neuro-oncology. This goal can be achieved with direct electrical stimulation (DES) to perform a functional mapping patients awake intraoperatively. When surgery not possible, we propose pipeline procedure that combines advanced techniques aiming at performing dissection respects anatomo-functional connectivity peritumoral region. benefit from intraoperative monitoring...